BDX 3.70% 14.0¢ bcal diagnostics limited

Ann: Change in substantial holding, page-6

  1. 9,786 Posts.
    lightbulb Created with Sketch. 966
    There is zero promotion of this stock. No webinars, conferences etc No LinkedIn promotion.

    The MD lives in the USA and the Executive Chairman and major shareholder Jayne Shaw is not one for small talk and has many business interests including the Sydney Breast Clinic which is an easy leg up for the BCAL blood test when operational later next year.

    Commercialisation in less than 12 months in Australia.

    BDX will be one of those stocks that will one day multibag out of the blue and investors sitting on the sidelines will wonder why they were not on board as it was so obvious. This day will come in 2024 imo.
 
watchlist Created with Sketch. Add BDX (ASX) to my watchlist
(20min delay)
Last
14.0¢
Change
0.005(3.70%)
Mkt cap ! $44.00M
Open High Low Value Volume
13.5¢ 14.0¢ 13.5¢ $22.29K 159.3K

Buyers (Bids)

No. Vol. Price($)
3 47554 14.0¢
 

Sellers (Offers)

Price($) Vol. No.
14.5¢ 150787 2
View Market Depth
Last trade - 16.10pm 05/07/2024 (20 minute delay) ?
BDX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.